Literature DB >> 23026660

Formation of the clot.

Bruce Furie1, Barbara C Furie.   

Abstract

An electron transport system regulates the initiation of thrombus formation through the activation of critical receptors involved in hemostasis and thrombosis. Protein disulfide isomerase along with other thiol isomerases, important for intracellular protein synthesis, are responsible for this extracellular activity during thrombus formation. Inhibition of these thiol isomerases blocks platelet aggregation and fibrin generation. Pharmaceuticals directed against these thiol isomerases offers a novel approach to antithrombotic therapy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026660      PMCID: PMC6089224          DOI: 10.1016/j.thromres.2012.08.272

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

Review 1.  Mechanisms of thrombus formation.

Authors:  Bruce Furie; Barbara C Furie
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

2.  Laser-induced endothelial cell activation supports fibrin formation.

Authors:  Ben T Atkinson; Reema Jasuja; Vivien M Chen; Prathima Nandivada; Bruce Furie; Barbara C Furie
Journal:  Blood       Date:  2010-07-30       Impact factor: 22.113

3.  Platelet PECAM-1 inhibits thrombus formation in vivo.

Authors:  Shahrokh Falati; Sonali Patil; Peter L Gross; Michelle Stapleton; Glenn Merrill-Skoloff; Natasha E Barrett; Katherine L Pixton; Harmut Weiler; Brian Cooley; Debra K Newman; Peter J Newman; Barbara C Furie; Bruce Furie; Jonathan M Gibbins
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

4.  Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.

Authors:  Christophe Dubois; Laurence Panicot-Dubois; Justin F Gainor; Barbara C Furie; Bruce Furie
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

5.  Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins.

Authors:  Jaehyung Cho; Daniel R Kennedy; Lin Lin; Mingdong Huang; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

6.  Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo.

Authors:  Reema Jasuja; Bruce Furie; Barbara C Furie
Journal:  Blood       Date:  2010-07-28       Impact factor: 22.113

7.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

8.  A critical role for extracellular protein disulfide isomerase during thrombus formation in mice.

Authors:  Jaehyung Cho; Barbara C Furie; Shaun R Coughlin; Bruce Furie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.

Authors:  Reema Jasuja; Freda H Passam; Daniel R Kennedy; Sarah H Kim; Lotte van Hessem; Lin Lin; Sheryl R Bowley; Sucharit S Joshi; James R Dilks; Bruce Furie; Barbara C Furie; Robert Flaumenhaft
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

10.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  3 in total

1.  Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.

Authors:  B Steppich; F Dobler; L C Brendel; G Hessling; S L Braun; A L Steinsiek; I Deisenhofer; A Hyseni; M Roest; I Ott
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

2.  Direct penetrating and indirect neck trauma as a cause of internal carotid artery thrombosis and secondary ischemic stroke.

Authors:  Karol Karnecki; Zbigniew Jankowski; Michał Kaliszan
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

3.  Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.

Authors:  Lisa-Marie Holbrook; Shirley J Keeton; Parvathy Sasikumar; Sophie Nock; Justine Gelzinis; Elizabeth Brunt; Sarah Ryan; Megan M Pantos; Christina A Verbetsky; Jonathan M Gibbins; Daniel R Kennedy
Journal:  Br J Pharmacol       Date:  2021-01-04       Impact factor: 9.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.